As founder of HUYA Bioscience International, Lady Mireille Gillings built a pioneering model to accelerate the global development of novel biopharmaceutical therapies originating in China.

On May 9, 2025, the Tianjin Municipal Administration for Market Regulation (“Tianjin AMR”) announced administrative penalties ...

In this Pharmaceutical Executive exclusive, Bob Jansen, David Shulkin, Gen. Paul Funk (Ret.), and Maj. Gen. Dennis LeMaster ...

Tina Freese Decker talks with Brian Pomper about the past and present state of U.S. tariff policy, how tariffs could impact hospital and health system operations, and ways health care leaders can ...

With the goal to become a top 3 pharma company in China, Novartis has been busy tapping into the expertise of local ...

TCG Labs Soleil’s Juri Biosciences is offering EpimAb Biotherapeutics up to $210 million biobucks for exclusive licensing ...

A cohort of MBA students traveled abroad to gain first-hand insights into China’s growing economy In an era of rapidly ...

In this interview, we chat to Dean Lee (Senior Expert I, Data Science, Novartis) about the big challenges in the life ...

Discover the key biotech trends moving the industry forward in Europe at a time when there lies uncertainty in global ...

Three-quarters of US-based researchers and graduate students are considering working abroad, according to a recent study.

They worry tariffs, aimed at bringing drug production to the United States, could instead drive companies out of business ...

Scientists have discovered a new bacteria species called niallia tiangongensis aboard China's Tiangong space station.